Fig. 3From: Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomasHeatmap of CE evolution pattern in patients with edema-dominant type and tumor-dominant type NEL. CE = contrast enhancement; NEL = non-enhancing lesionBack to article page